Rebecca Hubbard, PhD, co-led a new JNCI paper that studied >14k patients with advanced cancer in a national EHR database to show that time from diagnosis to treatment and choice of therapy did not change during the pandemic, even when accounting for differential timing of state stay-at-home orders.